張春梅,楊志英,李 磊
(1.山東省臨朐縣人民醫(yī)院產(chǎn)科,山東 臨朐 262600;2.山東省立醫(yī)院產(chǎn)科,山東 濟(jì)南 250021)
盆底肌功能訓(xùn)練防治產(chǎn)后盆底功能障礙性疾病療效
張春梅1,楊志英1,李 磊2
(1.山東省臨朐縣人民醫(yī)院產(chǎn)科,山東 臨朐 262600;2.山東省立醫(yī)院產(chǎn)科,山東 濟(jì)南 250021)
目的 探究并分析盆底肌功能訓(xùn)練預(yù)防和治療產(chǎn)后盆底功能障礙性疾病(PFD)的臨床效果。方法 選取2011年3月至2012年3月山東省臨朐縣人民醫(yī)院婦產(chǎn)科收治的100例足月經(jīng)陰道分娩的產(chǎn)婦為研究對(duì)象。按隨機(jī)數(shù)字表法將其分為觀察組和對(duì)照組,每組各50例。觀察組產(chǎn)婦產(chǎn)后采用盆底肌功能訓(xùn)練,對(duì)照組則進(jìn)行一般的健康教育。結(jié)果 觀察組產(chǎn)婦產(chǎn)后3個(gè)月的盆底肌力分級(jí)為Ⅳ、Ⅴ的人數(shù)分別為28例(56%)和12例(24%),明顯高于對(duì)照組(χ2值分別為31.55、8.31,均P<0.05)。觀察組產(chǎn)婦產(chǎn)后6周、3個(gè)月的排尿狀況評(píng)分及盆底肌收縮力評(píng)分分別為2.13±0.24、2.03±0.32、3.97±0.52、4.84±0.24,與對(duì)照組比較差異均有統(tǒng)計(jì)學(xué)意義(t值分別為5.367、4.654;4.825、7.467,均P<0.05)。觀察組產(chǎn)婦產(chǎn)后6周、3個(gè)月SUI的發(fā)生率分別為16%、10%,產(chǎn)后3個(gè)月腰骶酸痛、陰道松弛、陰道干澀的發(fā)生率分別為28%、14%、14%,均明顯低于對(duì)照組(χ2值分別為8.21、8.39、6.00、9.72、8.57,均P<0.05)。結(jié)論 盆底肌功能訓(xùn)練能顯著改善產(chǎn)后盆底肌力,對(duì)預(yù)防和治療產(chǎn)后PFD具有十分重要的意義,值得在臨床上推廣應(yīng)用。
盆底肌功能訓(xùn)練;健康教育;盆底肌功能障礙;療效
大多數(shù)女性在妊娠和分娩階段盆底功能受到一定的損傷,易患盆底功能障礙性疾病(pelvic floor dysfunctional disease,PFD)。為防止盆底功能障礙,孕婦產(chǎn)后行盆底肌康復(fù)治療顯得尤為重要[1]。常見的盆底肌康復(fù)治療方法有盆底肌肉鍛煉、生物反饋和電刺激等,盆底肌功能訓(xùn)練(pelvic floor muscle function training,PFMT)在臨床上對(duì)恢復(fù)盆底肌力作用顯著,對(duì)預(yù)防和治療PFD的作用已得到廣泛認(rèn)可。PFMT對(duì)產(chǎn)后盆底功能的恢復(fù)具有很好的促進(jìn)作用,明顯提高了產(chǎn)婦產(chǎn)后的生活質(zhì)量,是目前臨床上用于防治PFD的主要方法[2]。本研究針對(duì)產(chǎn)婦產(chǎn)后實(shí)行盆底肌功能鍛煉,旨在探究其對(duì)產(chǎn)婦產(chǎn)后盆底肌功能障礙性疾病的預(yù)防和治療效果,現(xiàn)將報(bào)告如下。
1.1 臨床資料
選取2011年3月至2012年3月山東省臨朐縣人民醫(yī)院婦產(chǎn)科收治的100例足月經(jīng)陰道分娩的產(chǎn)婦,將其作為臨床研究對(duì)象。入選標(biāo)準(zhǔn)[3]:認(rèn)知能力正常,自愿接受產(chǎn)后42天和6個(gè)月的盆底肌力評(píng)估以及PFD發(fā)生情況的調(diào)查。排除標(biāo)準(zhǔn):具有嚴(yán)重內(nèi)外科疾病者,生殖泌尿系統(tǒng)感染者。按隨機(jī)數(shù)表法將其分為觀察組(PFMT)和對(duì)照組(一般健康教育),每組各50例。
對(duì)照組產(chǎn)婦年齡在22~34歲,平均為28.2±4.5歲;孕周為37~39周,平均為38.2±0.3周,其中尿失禁患者15例,子宮脫垂9例,陰道壁膨出及會(huì)陰陰道裂傷26例。觀察組產(chǎn)婦年齡在21~35歲,平均為29.6±4.8歲;孕周為38~40周,平均為39.1±0.9周,其中尿失禁患者17例,子宮脫垂8例,陰道壁膨出及會(huì)陰陰道裂傷25例。所有孕婦產(chǎn)前經(jīng)B超檢查均為單胎妊娠,且無中孕引產(chǎn)史,產(chǎn)后42天對(duì)兩組患者進(jìn)行盆底肌力測(cè)定均<Ⅲ級(jí)。所有患者均在知情同意的情況下參與研究。兩組產(chǎn)婦一般資料無顯著性差異(均P>0.05),具有可比性。
1.2 方法
產(chǎn)科護(hù)士對(duì)對(duì)照組產(chǎn)婦產(chǎn)后進(jìn)行一般健康教育,未進(jìn)行系統(tǒng)指導(dǎo)。觀察組產(chǎn)婦產(chǎn)后在一般健康教育的基礎(chǔ)上于產(chǎn)后第6周開始行PFMT訓(xùn)練,首先向產(chǎn)婦講解PFMT的目的、方法以及訓(xùn)練開始的時(shí)機(jī)和訓(xùn)練過程中需要注意的問題,按照凱格爾鍛煉法進(jìn)行PFMT練習(xí),方法如下:產(chǎn)婦平臥床上,分開雙腿并稍屈曲,指導(dǎo)產(chǎn)婦在吸氣時(shí)收縮肛門,盡力收縮并持續(xù)6~8秒,呼氣時(shí)則松弛肛門,放輕松即可,不需盡力收縮肛門。按照上述方法每天反復(fù)練習(xí),直到熟練,每天3次,每次訓(xùn)練30min,連續(xù)訓(xùn)練4~6周,在訓(xùn)練過程中應(yīng)注意避免腹部吸氣加壓,同時(shí)避免腿部及臀部肌肉參與訓(xùn)練。對(duì)于動(dòng)作熟練的產(chǎn)婦保持站位、坐位及臥位均可進(jìn)行PFMT訓(xùn)練,根據(jù)產(chǎn)婦訓(xùn)練情況逐漸延長(zhǎng)每次收縮時(shí)間及訓(xùn)練時(shí)間[4-5]。
1.3 觀察指標(biāo)
比較兩組產(chǎn)婦產(chǎn)后3個(gè)月的盆底肌力分級(jí)情況,分級(jí)標(biāo)準(zhǔn)[2]:肌肉僅收縮1次,且收縮時(shí)間<1秒,記為Ⅰ級(jí);肌肉能收縮2次,且時(shí)間可維持2秒,記為Ⅱ級(jí);肌肉收縮完全,無對(duì)抗,能收縮3次,且時(shí)間可維持3秒,記為Ⅲ級(jí);肌肉完全收縮,輕微對(duì)抗,并且收縮次數(shù)為4次,持續(xù)4秒,記為Ⅳ級(jí);肌肉完全收縮,持續(xù)對(duì)抗,收縮5次且持續(xù)時(shí)間>5秒,記為Ⅴ級(jí),其中肌力<Ⅲ級(jí)表示肌力異常。分別測(cè)量產(chǎn)后6周、3個(gè)月的排尿狀況評(píng)分及盆底肌收縮力評(píng)分情況,并對(duì)兩組產(chǎn)婦PFMT后壓力性尿失禁(SUI)及盆底功能受損癥狀的發(fā)生率進(jìn)行比較。
1.4 統(tǒng)計(jì)學(xué)方法
2.1 兩組產(chǎn)婦產(chǎn)后3個(gè)月盆底肌力的情況
觀察組產(chǎn)婦產(chǎn)后3個(gè)月的盆底肌力分級(jí)為Ⅳ、Ⅴ的人數(shù)明顯多于對(duì)照組,組間比較差異有統(tǒng)計(jì)學(xué)意義(均P<0.05),見表1。
表1 兩組產(chǎn)婦產(chǎn)后3個(gè)月盆底肌力的比較[n(%)]
Table 1 Comparison of pelvic floor muscle strength three months after delivery between two groups[n(%)]
2.2 兩組產(chǎn)婦產(chǎn)后6周和3個(gè)月的排尿狀況評(píng)分及盆底肌收縮力評(píng)分情況
觀察組產(chǎn)婦產(chǎn)后6周、3個(gè)月的排尿狀況評(píng)分均低于對(duì)照組,而盆底肌收縮力評(píng)分均高于對(duì)照組,組間比較差異均有統(tǒng)計(jì)學(xué)意義(均P<0.05),見表2。
2.3 兩組產(chǎn)婦產(chǎn)后6周和3個(gè)月壓力性尿失禁發(fā)生率情況
與對(duì)照組比較,觀察組產(chǎn)婦產(chǎn)后6周、3個(gè)月SUI的發(fā)生率均明顯較低,組間比較差異均有統(tǒng)計(jì)學(xué)意義(均P<0.05),見表3。
表3 兩組產(chǎn)婦產(chǎn)后6周、3個(gè)月SUI發(fā)生率的比較[n(%)]
Table 3 Comparison of SUI incidence 6 weeks and 3 months after delivery between two groups[n(%)]
2.4 兩組產(chǎn)婦產(chǎn)后3個(gè)月的盆底功能受損情況
觀察組產(chǎn)婦產(chǎn)后3個(gè)月盆底功能受損癥狀較對(duì)照組明顯偏低,腰骶酸痛、陰道松弛、陰道干澀的發(fā)生率明顯低于對(duì)照組,組間比較差異均有統(tǒng)計(jì)學(xué)意義(均P<0.05),兩組尿頻、尿急的發(fā)生率比較差異無統(tǒng)計(jì)學(xué)意義(P>0.05),見表4。
表4 兩組產(chǎn)婦產(chǎn)后3個(gè)月的盆底功能受損情況[n(%)]
Table 4 Comparison of pelvic floor function damage 3 months after delivery between two groups[n(%)]
3.1 產(chǎn)后盆底肌功能訓(xùn)練的重要性
孕婦盆底在妊娠期間已存在一定程度的損傷,再加之陰道分娩時(shí)盆底組織、筋膜、韌帶等的過度牽拉,從而導(dǎo)致盆底功能進(jìn)一步受損,這種盆底損傷大多數(shù)情況下是可逆的,但嚴(yán)重者有可能發(fā)生不可逆的損傷,因而妊娠和分娩是導(dǎo)致PFD的高危因素[6-7]。有研究顯示,除妊娠和分娩外,多產(chǎn)、巨大兒、會(huì)陰裂傷、第二產(chǎn)程延長(zhǎng)等因素也會(huì)損傷盆底肌肉、神經(jīng)及結(jié)締組織,對(duì)尿道橫紋肌也有一定損傷,容易導(dǎo)致PFD的發(fā)生[8]。常見的PFD有SUI、便失禁、生殖器官脫垂和性功能障礙等,其中SUI最為常見,產(chǎn)后發(fā)病率較高。SUI是指咳嗽、大笑、運(yùn)動(dòng)等因素引起的腹壓突然升高而造成尿液不自主溢出,SUI的發(fā)生是由于各種原因?qū)е碌呐璧捉钅そM織松弛,膀胱及尿道后角發(fā)生改變,從而降低了尿道的阻力,使排尿失去控制[9-10]。因此,產(chǎn)后應(yīng)及時(shí)對(duì)盆底肌力進(jìn)行檢查,預(yù)防和治療盆底肌力下降,減少盆底肌功能障礙性疾病的發(fā)生[11]。
3.2 產(chǎn)后盆底肌功能訓(xùn)練的意義
目前,可用于預(yù)防和治療產(chǎn)婦產(chǎn)后PFD的措施有盆底肌鍛煉、生物反饋及電刺激,臨床應(yīng)用以PFMT最為常見。PFMT在臨床上又稱為肛門收縮運(yùn)動(dòng),通過有意識(shí)、有節(jié)律收縮肛門運(yùn)動(dòng),可使尿道口、陰道及肛門周圍的肌肉同時(shí)收縮和松弛,一方面可以使盆底肌的緊張度和收縮力增加,另一方面又能使盆底肌的血液循環(huán)得到改善,幫助盆底肌恢復(fù)張力,起到預(yù)防盆底肌張力減退導(dǎo)致SUI的發(fā)生[12]。
3.3 產(chǎn)后盆底肌功能訓(xùn)練的效果
本文探究了PFMT在孕婦產(chǎn)后盆底肌功能障礙性疾病中的防治效果,通過對(duì)產(chǎn)后盆底肌力的評(píng)估及盆底肌受損癥狀、SUI發(fā)生率調(diào)查情況可知,觀察組產(chǎn)婦產(chǎn)后3個(gè)月的盆底肌力以Ⅳ、Ⅴ的人數(shù)明顯多于對(duì)照組(均P<0.05);觀察組產(chǎn)婦產(chǎn)后6周和3個(gè)月的排尿狀況評(píng)分均低于對(duì)照組,而盆底肌收縮力評(píng)分均高于對(duì)照組(均P<0.05);觀察組產(chǎn)婦產(chǎn)后6周和3個(gè)月SUI的發(fā)生率均明顯低于對(duì)照組(均P<0.05),此結(jié)果表明PFMT能明顯改善盆底肌力,促進(jìn)盆底肌張力的恢復(fù),從而減少SUI的發(fā)生。觀察組產(chǎn)婦產(chǎn)后3個(gè)月盆底功能受損癥狀腰骶酸痛、陰道松弛、陰道干澀的發(fā)生率均明顯低于對(duì)照組,進(jìn)一步說明,PFMT能增強(qiáng)產(chǎn)后盆底肌收縮能力,對(duì)產(chǎn)后盆底功能受損癥狀具有很好的改善效果。Sriboonreung等[13]的研究與本文結(jié)果較為相似,其研究證實(shí)產(chǎn)后早期行PFMT可促進(jìn)盆底肌力的恢復(fù),并減少SUI的發(fā)生率。
綜上所述,PFMT可作為產(chǎn)婦產(chǎn)后盆底肌功能障礙性疾病防治的首選措施,不僅有利于產(chǎn)后受損盆底肌的恢復(fù),對(duì)防治SUI的效果也較理想。
[1]劉秋芬.盆底肌肉康復(fù)治療在產(chǎn)科中的應(yīng)用[J].臨床合理用藥,2011,4(3A):103-104.
[2]周菊英.功能鍛煉與電刺激聯(lián)合生物反饋對(duì)產(chǎn)后盆底功能障礙的療效[J].中國(guó)婦幼健康研究, 2014, 25(6) : 1019-1021.
[3]豐有吉,沈鏗.婦產(chǎn)科學(xué)[M].北京:人民衛(wèi)生出版社,2010:281.
[4]Persu C, Chapple C R, Cauni V,etal.Pelvic Organ Prolapse Quantification System(POP-Q)-A new era in pelvic prolapse staging[J].J Med Life,2011,4(1):75-81.
[5]Kashanian M, Ali S S, Nazemi M,etal.Evalution of the effect of pelvic floor muscle training (PFMT or Kegel exercise) and assisted pelvic floor muscle training (APFMT) by a resistance device (Kegelmaster device) on the urinary incontinence in women :a randomized trial[J]. Eur J Obstet Gynecol Reprod Biol,2011,159(1):218-223.
[6]Unger C A, Weinstein M M, Pretorius D H.Pelvic floor imaging[J].Obstet Gynecd Clin North Am,2011,38(1):23-43.
[7]Kepenekci I, Keskinkilic B, Akinsu F,etal.Prevalence of pelvic floor disorders in the female population and the impact of age, mode of delivery, and parity[J].Dis Colon Rectum,2011,54(1):85-94.
[8]Bortolini M A, Drutz H P, Lovatsis D,etal.Vaginal delivery and pelvic floor dysfunction: current evidence and implications for future research[J].Int Urogynecol J,2010,21(8):1025-1030.
[9]Memon H U, Handa V L.Vaginal childbirth and pelvic floor disorders[J].Womens Health (Lond Engl),2013,9(3):265-277.
[10]Wesnes S L, Lose G.Preventing urinary incontinence during pregnancy and postpartum:a review[J]. Int Urogynecol J,2013,24(6):889-899.
[11]Park S H, Kang C B, Jang S Y,etal. Effect of Kegel exercise to prevent urinary and fecal incontinence in antenatal and postnatal women:systematic review[J]. J Korean Acad Nurs, 2013,43(3):420-430.
[12]楊曉,劉玉玲.盆底肌肉訓(xùn)練對(duì)產(chǎn)后盆底功能障礙的效果分析[J].國(guó)際婦產(chǎn)科學(xué)雜志,2013,40(2):164-166.
[13]Sriboonreung T, Wongtra-ngan S, Eungpinichpong W,etal.Effectiveness of pelvic floor muscle training in incontinent women at Maharaj Nakorn Chiang Mai Hospital:a randomized controlled trial[J].J Med Assoc Thai,2011,94(1):1-7.
[專業(yè)責(zé)任編輯:韓 蓁]
Curative effect of pelvic floor muscle function training on prevention and treatment of postpartum pelvic floor dysfunction
ZHANG Chun-mei1, YANG Zhi-ying1, LI Lei2
(1.DepartmentofObstetrics,LinquCountyPeople’sHospitalofShandongProvince,ShandongLinqu262600,China;2.DepartmentofObstetrics,ShandongProvincePeople’sHospital,ShandongJinan250021,China)
Objective To explore and analyze the clinical effect of pelvic floor muscle function training (PFMT) on prevention and treatment of postpartum pelvic floor dysfunction (PFD). Methods From March 2011 to March 2012 100 cases of vaginal delivery admitted to obstetrics and gynecology department of Linqu County People’s Hospital of Shandong Province were selected in the study, and they were divided into observation group and control group with 50 cases in each group according to random number table method. The observation group accepted postpartum PFMT, while the control group accepted postpartum general health education. Results The number of cases with pelvic floor muscle strength graded Ⅳ and Ⅴ 3 months after birth was 31 (62%) and 12 (24%), respectively in the observation group, which was significantly more than the control group (χ2value was 31.55 and 8.31, respectively, bothP<0.05). In the observation group 6 weeks and 3 months after birth, the voiding condition scores and pelvic floor muscle contraction scores were 2.13±0.24, 2.03±0.32, 3.97±0.52 and 4.84±0.24, respectively, which were significantly different from those in the control group (tvalue was 5.367, 4.654, 4.825, and 7.467, respectively, allP<0.05). The incidence of SUI in the observation group was 16% and 10%, respectively at 6 weeks and 3 months after birth, and that of lumbosacral pain, vaginal relaxation and vaginal dryness was 28%, 14% and 14%, respectively, which were significantly lower than the control group (χ2value was 8.21, 8.39, 6.00, 9.72 and 8.57, respectively, allP<0.05). Conclusion PFMT can significantly improve the function of postpartum pelvic floor muscle strength, which is essential to the prevention and treatment of postpartum PFD and worthy of clinical application.
pelvic floor muscle function training (PFMT);health education;pelvic floor muscle dysfunction;efficacy
2015-01-22
張春梅(1979-),女,主治醫(yī)師,主要從事產(chǎn)科臨床工作。
楊志英,主任醫(yī)師。
10.3969/j.issn.1673-5293.2015.04.036
R714
A
1673-5293(2015)04-0763-03